Fulton appoints new management team

Restructures Bristol-based business

Fulton was established in Bristol, UK in 1966 to manufacture vertical tubeless steam boilers. Today the company is part of Fulton Inc, a global manufacturer of steam, hot water and thermal fluid heat transfer systems with production facilities in the UK, US and China.

Following the retirement of the UK firm’s sales and marketing and technical directors, Fulton Inc has restructured the business and appointed Paul Richards as managing director and Carl Knight as UK and European sales and marketing manager.

Richards previously worked for Solatron, while Knight joins Fulton from Spirax Sarco.

Richards said: ‘The changes haven’t just stopped with management appointments. We have also restructured and changed the trading name from Fulton Boiler Works (GB) to Fulton, as we feel it better reflects the business and markets we now operate in.’

Once just a steam boiler manufacturer, Fulton now specialises in the design and manufacture of energy efficient products and ready-to-ship skid mounted and fully packaged boiler plant rooms, he added.

‘We put great emphasis on providing sales and application advice and a full commissioning and after sales service to a growing customer base in hospital and healthcare facilities, food and beverage processing, laundries and other applications.’

Fulton recently introduced of a VMP vertical tubeless boiler, ModSync boiler sequencing system and TDS energy recovery system.

You may also like

Manufacturing

Reliable, high-performance pump for HPLC and UHPLC

Biotech Fluidics announce the ASI 540 – an affordable, standalone solvent delivery pump - design optimised for liquid chromatography applications
Manufacturing

BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech

The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing

Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform

The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services collaborate to support ADC development and manufacturing

Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Manufacturing

Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases

Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the development cycle
Manufacturing

FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing

A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
Subscribe now